Sanara MedTech Inc. (SMTI) Stock

Sanara MedTech Inc. (SMTI) is a Healthcare stock trading at $21.88 (as of 2026-06-18), with a market capitalization of $208.85M and a trailing P/E of -5.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products in the United States, including surgical and wound dressings and related extracellular-matrix and collagen-based therapies. Its products are used by physicians and provided through hospitals, clinics, and post-acute care settings.

Valuation — source: SEC EDGAR (first-party)
Price$21.88
Market Cap$208.85M
P/E Ratio-5.8
EV / EBITDA15.7
Price / Book29.75
Price / Sales1.94
DCF Value (model)$0.81
DCF Upside vs Price-96.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$103.12M
Net Margin-36.4%
Return on Equity-478.3%
Debt / Equity6.67
Current Ratio2.28
Revenue Growth (YoY)19.0%
EPS Growth (YoY)282.5%
FCF Growth (YoY)-1041.1%
Financial Health — source: SEC EDGAR
Altman Z-Score2.34 (grey)
Piotroski F-Score4/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-5.8
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-127.9%
vs Industry-118.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($4.28M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOSeth D. Yon
Employees141
CountryUS
IPO Date1994-04-07

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Orchestra BioMed Holdings, Inc. (OBIO)
  • Quantum-Si incorporated (QSI)
  • Stereotaxis, Inc. (STXS)
  • Anteris Technologies Global Corp. (AVR)
  • Nyxoah S.A. (NYXH)
  • Nano-X Imaging Ltd. (NNOX)
  • 908 Devices Inc. (MASS)
  • CVRx, Inc. (CVRX)
SMTI earnings history · SMTI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.